fluticasone furoate and vilanterol inhalation powder

Fluticasone is used to treat seasonal and year-round allergy symptoms such as stuffy/runny nose, itching, and sneezing. It may also reduce other symptoms of seasonal allergies such as red, itchy, and watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) in the nasal passages.

Are you looking for or in search of FDA approved “sacituzumab govitecan-hziy for injection in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Breast Cancer. Need Access of sacituzumab govitecan-hziy injection, get in touch with our healthcare professional.

fluticasone furoate and vilanterol inhalation powder price in Latin America, Russia, UK & USA
fluticasone furoate and vilanterol inhalation powder

Fluticasone furoate/vilanterol (FF/VI), sold under the brand name Breo Ellipta among others, is a combination medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains fluticasone furoate, an inhaled corticosteroid, and vilanterol, an ultra-long-acting β2 agonist (ultra-LABA).

This drug was approved by the FDA for use as a long-term, once-daily, maintenance treatment in people with COPD in 2013. Labeling changed on April 30, 2015, to add an indication for a once-daily treatment of asthma in people 18 years or older. The exclusivity for a new product ended in May 2016, in the United States, and the exclusivity on the indication for asthma expired on April 30, 2018.] The patent for both indications expires on August 3, 2021.[9] The European Medicines Agency approved the drug for marketing on November 13, 2013.

    fluticasone furoate and vilanterol inhalation powder

    Contact No.

    Call us
    +91 11 4350 7259

    Emergency Contact
    +91 93139 48015


    Visit us anytime
    F-90/1 , Okhla Industrial Area,
    Phase -1 , New Delhi. India

    Send us an email